Still, Medtronic executives have said their new device, called Inceptiv, is a game changer that they expect to “revolutionize ...

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Medtronic (NYSE: MDT) today announced 12-month data demonstrating the benefits of its Inceptiv closed-loop spinal cord stimulator (CL-SCS).

A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

Spinal Cord Stimulators Market. The global spinal cord stimulators market is on an accelerated growth path, projected to ...

A new FDA-approved device is bringing hope to people who have suffered spinal injuries and helping them regain function they ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

and neuromodulation products (spinal cord stimulation. brain modulation that treats things like Parkinson's symptoms, and implantable drug infusions for chronic pain). Medtronic has several ...